Topical ophthalmic medications used on the ward and from the outpatient area have been taken and cultured for potential bacterial contamination in the laboratory. We examined 143 bottles used by patients who had had routine cataract surgery and trabeculectomy. We also examined for bacterial contamination 216 bottles of eyedrops used in the outpatient area of the hospital. No contamination was found in the postoperative eyedrops, but five bottles were contaminated from the outpatient area (2.3%). The bacterial growth from outpatient drops was of the same order of magnitude as in previous studies. The practice in the UK for postoperative eyedrops to be discarded and fresh, separate bottles to take home is discussed. We recommend that this practice be changed so that the postoperative drops used for 72 hours or less are taken home.
The duration of inpatient stay has decreased steadily in the UK with decreasing time of postoperative stay' 2 (Fig 1) . Many patients are now discharged the evening following surgery or the next day. We wished to assess whether shortstay patients having routine surgery who used postoperative eyedrops had contamination of these drops on leaving hospital. Since in a pilot study we had failed to detect contamination in these bottles, we attempted to assess the efficacy of the bacterial assay by culturing multiuse bottles used in the outpatient area of Moorfields Eye Hospital.
Previous studies have been performed on the contamination of ocular medications, and variable growth of bacterial contaminants has been obtained.3-" One study in an ophthalmic outpatient clinic found tear contamination of eye-dropper bottles,'2 and a number of studies have commented on the inhibition of growth of bacteria by preservatives. The survival of organisms has been found in the bottle dead space and cap.'3- '5 There has been improvement in the efficacy of preservatives used in eyedrop preparations,'3"'""" and modern multidrop bottles may be expected to have a very low level of contamination with viable bacterial organisms. To test the efficacy of antimicrobial presevative the British Pharmacopoeia Commission set up a working party in 1988 to study multidose ophthalmic products. Eyedrops were selected owing to their differing preservatives, their initial sterility, and their frequency of use. 9 Four different preparations were studied, and contamination was found in 5% of 604 samples. Only low levels of contamination were generally found, with higher levels restricted to a few samples containing coagulase-negative staphylococci.
In the United Kingdom it is policy that unidrop dispensers are used for external disease clinic outpatients and all patients for a casualty department owing to Plates examined for bacterial growth Figure 2 Methodfor culture ofeyedrops. ferences in incidence. '9 Whether there is a difference in preservative efficacy was not addressed in this study, but it is interesting that the five contaminated bottles all used benzalkonium chloride as the preservative. The study ofthe British Pharmacopoeia Commission found that samples with relatively high bacterial counts were those from bottles preserved with thiomersal,'9 and the continued use of thiomersal in eyedrops has been questioned. 3 We have not found contamination in thiomersal preserved bottles, but in our study only 13 bottles using this preservative were collected from the outpatient clinics. Whichever preservative is used, multidrop dropper bottles are known to be a vector for potential contamination from one patient to another'2 and care should be exercised in the drop application technique.
The use of multidrop bottles in outpatient areas where a bottle is used for different patients is potentially a source of interpatient contamination. Ideally only unidrop disposable eyedrop containers would be used, but they can cost more than multidrop bottles. For any patient that might be infected or have external eye disease a unidrop dispenser should be used. Alternatively the multidrop bottle could be discarded after use with an infected or potentially infected patient.
We have not recorded if some of the bottles in this study were discarded by clinic staff after such use. We did not find any bacterial contamination of inpatient postoperative eyedrops for cataract and trabeculectomy patients. For these routine, noninfected, short-stay patients we propose that, to save costs and to increase efficiency, medical staff should prescribe postoperative drops at the postoperative ward round, and patients should use them both on the ward and to take home, provided the bottle has not been open for longer than 72 hours. Since this study has reviewed postoperative contamination only for short-stay patients, we cannot exclude contamination of bottles opened for longer periods of time.
Not replacing the postoperative eyedrops used on the ward and allowing patients to take the same bottles home would reduce postoperative drug costs by up to 50% (Fig 3) . There would also be a reduction of work load for ward, medical, and pharmacy staff. Mistakes and omissions should also decrease. Patients on being discharged do not have to wait for their drops to arrive from the hospital pharmacy, and can leave hospital much quicker, so vacating a bed sooner.
On admission to hospital, instruction is given by nursing staff in technique of instillation. By dispensing the same drops on the ward as will be used at home, the time in hospital allows patients to practice instilling the same drops. Patients would not become confused by a different brand of eyedrop being dispensed just prior to leaving hospital.
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